ArriVent BioPharma Statistics
NASDAQ: AVBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
16.71-0.18 (-1.07%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
ArriVent BioPharma by the numbers
ArriVent BioPharma has a market capitalization of $823.9 million based on 49.31M shares outstanding. With trailing EPS of $-3.62, ArriVent BioPharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 42.4% below its 50-day average and 38.7% below its 200-day average.
Average daily trading volume is 908.55K shares, or about $15.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AVBP valuation vs. peer median
| Metric | AVBP | Peer median | Difference |
|---|---|---|---|
| Market cap | $823.93M | $784.04M | +5% |
| Avg. volume | 908.55K | 1.52M | -40% |
Peer median across 8 companies: CYRX, CRVS, IVA, GERN, HELP, LXRX, IMMX, JBIO.
Valuation
- Market cap
- $823.93M
- EPS (TTM)
- $-3.62
- Shares outstanding
- 49.31M
Price and trading
- Previous close
- 16.89
- Open
- 16.61
- Day range
- 15.78 – 16.89
- 52-week range
- 11.36 – 35.83
- 52-week change
- -19.74%
- Beta
- —
- Volume
- 2.15M
- Average volume
- 908.55K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 16, 2026
Additional statistics
- Market Cap
- 823.93M
- Forward Pe
- -4.28
- Eps
- -3.62
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 35.83
- Week52 Low
- 11.36
- Avg Volume
- 908.55K
- Shares Outstanding
- 49.31M
- Ma50
- 29.02
- Ma200
- 27.27
- Earnings Date
- Nov 16, 2026
- Pct From52w High
- -53.36%
- Pct From52w Low
- 47.10%